1. Home
  2. ZEO vs GANX Comparison

ZEO vs GANX Comparison

Compare ZEO & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZEO
  • GANX
  • Stock Information
  • Founded
  • ZEO 2005
  • GANX 2017
  • Country
  • ZEO United States
  • GANX United States
  • Employees
  • ZEO N/A
  • GANX N/A
  • Industry
  • ZEO
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZEO
  • GANX Health Care
  • Exchange
  • ZEO NYSE
  • GANX Nasdaq
  • Market Cap
  • ZEO 55.5M
  • GANX 53.8M
  • IPO Year
  • ZEO N/A
  • GANX 2021
  • Fundamental
  • Price
  • ZEO $2.38
  • GANX $1.86
  • Analyst Decision
  • ZEO
  • GANX Strong Buy
  • Analyst Count
  • ZEO 0
  • GANX 5
  • Target Price
  • ZEO N/A
  • GANX $8.20
  • AVG Volume (30 Days)
  • ZEO 90.1K
  • GANX 309.6K
  • Earning Date
  • ZEO 08-18-2025
  • GANX 08-07-2025
  • Dividend Yield
  • ZEO N/A
  • GANX N/A
  • EPS Growth
  • ZEO N/A
  • GANX N/A
  • EPS
  • ZEO N/A
  • GANX N/A
  • Revenue
  • ZEO $61,885,622.00
  • GANX N/A
  • Revenue This Year
  • ZEO N/A
  • GANX N/A
  • Revenue Next Year
  • ZEO N/A
  • GANX N/A
  • P/E Ratio
  • ZEO N/A
  • GANX N/A
  • Revenue Growth
  • ZEO N/A
  • GANX N/A
  • 52 Week Low
  • ZEO $1.05
  • GANX $0.89
  • 52 Week High
  • ZEO $4.75
  • GANX $3.19
  • Technical
  • Relative Strength Index (RSI)
  • ZEO 40.30
  • GANX 53.85
  • Support Level
  • ZEO $2.66
  • GANX $1.70
  • Resistance Level
  • ZEO $2.80
  • GANX $1.84
  • Average True Range (ATR)
  • ZEO 0.24
  • GANX 0.16
  • MACD
  • ZEO -0.10
  • GANX 0.01
  • Stochastic Oscillator
  • ZEO 0.00
  • GANX 62.75

About ZEO ZEO ENERGY CORP

Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy-efficient equipment, and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: